GLP2-T TRZ 15 mg
Description
TIRZ 10, 15, 20, 30, 40, 60 MG
GLP2-TRZ (Research Grade Peptide) — Dual-Pathway Incretin Analog
Overview
GLP2-TRZ is a research-grade dual-pathway incretin analog engineered for in vitro investigation of receptor pharmacology. Supplied as a lyophilized peptide for stability and analytical precision; QC-verified for sequence fidelity and batch purity.
Research context
Intended for non-clinical studies, GLP2-TRZ is used to probe combined GLP-1 and GIP receptor activity.
Product Information
- Product nameGLP2-TRZ
- FormulaC225H348N48O68
- Molecular weight~4813.5 g/mol
- CAS number2023788-19-2
- AppearanceWhite to off-white lyophilized powder
- FormLyophilized solid
- Purity>99% (HPLC verified)
Storage & Handling
- Store at −20 °C; protect from moisture and light.
- Lyophilized for stability; avoid repeated freeze–thaw cycles after reconstitution.
- Follow institutional protocols for reconstitution and aseptic handling.
Research Applications
- In vitro GLP-1 / GIP receptor binding and signaling assays
- Cellular metabolic and cAMP pathway studies
- Mechanistic combination studies with incretin-pathway agents
- Advanced metabolic pathway modeling
Legal & Safety
For laboratory research use only. Not a drug, food, cosmetic, or medical device. Not for human or veterinary use. No therapeutic, diagnostic, or dosing claims are made. This product has not been evaluated by the U.S. Food and Drug Administration (FDA) and is not intended to diagnose, treat, cure, or prevent any disease.
